All stocks · MANKIND
MP

Mankind Pharma Limited

MANKIND BSE Healthcare

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeuti…

ISIN INE634S01028
Listed —
Quarters tracked 13
Filings 9 docs

About

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural and pet food products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Telmikind-Am, Gudcef, Glimestar-M, Candi Force, Nurokind-Gold, Telmikind-H, Telmikind, Nurokind-Lc, Nurokind Plus-Rf, Vomikind, Cefakind, Glizid-M, Monticope, and Gudcef-Cv brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap97,129 Cr
P/E45.60
Div Yield0.04 %
Book Value₹395.00
52w High₹2,674.00
52w Low₹1,910.00
Face Value₹1.00

Quarterly Results

Rs. Crores · hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 2,964.00 2,582.00 2,633.00 2,609.00 2,570.00 2,119.00 2,414.00 2,544.00 2,413.00 2,007.00 2,209.00 2,260.00 2,092.00
Expenses 2,035.00 1,663.00 1,854.00 1,916.00 1,885.00 1,778.00 1,668.00 1,781.00 1,837.00 1,482.00 1,636.00 1,662.00 1,594.00
Operating Profit 929.00 919.00 778.00 693.00 685.00 342.00 746.00 763.00 576.00 526.00 573.00 598.00 498.00
OPM % 31.00 36.00 30.00 27.00 27.00 16.00 31.00 30.00 24.00 26.00 26.00 26.00 24.00
Other Income 34.00 104.00 -27.00 78.00 65.00 220.00 70.00 139.00 125.00 109.00 92.00 84.00 87.00
Depreciation 111.00 109.00 108.00 99.00 105.00 115.00 91.00 90.00 91.00 87.00 90.00 77.00 69.00
Interest 95.00 125.00 138.00 147.00 149.00 162.00 200.00 3.00 7.00 4.00 4.00 4.00 2.00
Profit before tax 757.00 788.00 505.00 525.00 496.00 284.00 525.00 810.00 603.00 543.00 571.00 601.00 514.00
Tax % 26.00 9.00 11.00 13.00 16.00 16.00 22.00 20.00 16.00 14.00 15.00 21.00 20.00
Net Profit 558.00 714.00 449.00 459.00 415.00 238.00 412.00 645.00 506.00 468.00 487.00 473.00 409.00
EPS in Rs 13.52 17.29 10.87 11.12 10.06 5.77 9.99 16.11 12.62 11.68 12.16 11.80 10.22

Profit & Loss

Annual · Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales 10,421.009,507.008,629.008,127.007,486.005,530.004,794.003,829.003,918.00
Expenses 7,333.007,082.006,358.006,429.005,644.004,151.003,550.003,124.003,141.00
Operating Profit 3,088.002,425.002,272.001,698.001,842.001,379.001,244.00705.00778.00
OPM % 30.0026.0026.0021.0025.0025.0026.0018.0020.00
Other Income 218.00555.00369.00163.00200.00148.0094.0064.00209.00
Interest 562.00378.0017.0028.0048.008.0011.0040.0018.00
Depreciation 429.00395.00335.00270.00123.0078.0062.0038.0028.00
Profit before tax 2,315.002,208.002,289.001,563.001,871.001,440.001,265.00691.00941.00
Tax % 12.0019.0018.0020.0026.0025.0024.0026.0026.00
Net Profit 2,038.001,786.001,876.001,248.001,389.001,084.00958.00514.00694.00
EPS in Rs 49.3643.2946.8431.1634.6827.0723.9212.8317.33
Dividend Payout % 2.000.000.000.000.000.0032.000.000.00

Balance Sheet

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital 41.0041.0040.0040.0040.0040.0040.0040.0040.00
Reserves 16,356.0014,281.009,663.007,744.006,500.004,694.003,611.003,025.002,957.00
Borrowings 5,571.007,383.0024.005.00688.00101.003.00190.00360.00
Other Liabilities 2,658.002,752.001,790.001,583.001,710.001,045.00877.00596.00652.00
Total Liabilities 24,625.0024,458.0011,516.009,371.008,939.005,880.004,531.003,851.004,009.00
Fixed Assets 3,926.004,076.003,552.003,142.002,927.00987.00945.00778.00534.00
CWIP 420.00207.00209.00495.00387.00166.00148.00211.00322.00
Investments 16,523.0016,683.004,215.003,102.002,526.002,397.001,784.001,698.001,402.00
Other Assets 3,756.003,491.003,540.002,632.003,100.002,330.001,655.001,164.001,751.00
Total Assets 24,625.0024,458.0011,516.009,371.008,939.005,880.004,531.003,851.004,009.00

Cash Flows

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Cash from Operating Activity 2,752.002,350.001,736.001,799.00821.001,022.00960.00537.00540.00
Cash from Investing Activity -388.00-12,178.00-1,665.00-1,041.00-1,360.00-1,127.00-396.00-306.00-516.00
Cash from Financing Activity -2,477.009,816.00-5.00-710.00579.0089.00-559.00-240.008.00
Net Cash Flow -113.00-11.0066.0048.0040.00-16.005.00-9.0031.00
Free Cash Flow 2,317.001,996.001,456.001,219.00-1,360.00830.00795.00371.00309.00
CFO/OP % 104.00116.0095.00123.0070.00103.0099.00111.00102.00

Ratios

Annual · Days / % — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Debtor Days 41.0035.0033.0022.0023.0024.0032.0013.0023.00
Inventory Days 151.00154.00160.00132.00183.00169.00124.00126.00120.00
Days Payable 95.0080.0075.00103.00133.00122.00113.00101.00115.00
Cash Conversion Cycle 97.00109.00118.0052.0073.0072.0043.0038.0027.00
Working Capital Days -87.00-81.0055.0040.0026.0042.0041.0044.0095.00
ROCE % 14.0015.0024.0021.0030.0033.0036.0022.00—

Shareholding Pattern

% holding — latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 72.63 72.66 72.66 72.67 72.67 72.70 72.71 74.87 74.87 74.88 76.50 76.50
FIIs 9.45 10.24 11.34 12.83 13.07 12.92 13.34 12.37 11.58 9.87 6.74 4.18
DIIs 15.39 14.46 13.26 11.91 11.50 11.47 11.05 9.91 9.94 11.14 9.78 4.56
Public 2.53 2.63 2.75 2.57 2.75 2.89 2.89 2.86 3.61 4.10 6.97 14.76
No. of Shareholders 166,715 177,606 177,539 170,347 179,549 180,597 171,281 163,854 153,450 135,116 127,449 134,731

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (₹)Notes
Dividend 08 Aug 2025 08 Aug 2025 — 1.00

Announcements

5 filings

Shareholding Pattern

Open on BSE

Financial Results — Filings

Open on BSE

Board Filings

Open on BSE

Annual Reports

Credit Ratings

Conference Calls

Back to all stocks